Human immunodeficiency virus type 1 (HIV-1
Introduction
The accessory protein Vif (virion infectivity factor) of human immunodeficiency virus type 1 (HIV-1) is a late nonstructural gene product which has been found to be conserved among most lentiviruses (Oberste & Gonda, 1992 ; Sova & Volsky, 1993) . On the basis of biochemical and electron microscopic data (Gabuzda et al., 1992 ; Ho$ glund et al., 1994 ; von Schwedler et al., 1993) , it has been hypothesized that its role in virus infectivity occurs at the level of virion assembly. HIV-1 Vif(k) virions have been found to be defective in the early steps of the virus life-cycle, and it is still debated whether their Vif-defective phenotype results from incorrect core protein packing and\or maturation as seen under the electron Author for correspondence : Pierre Boulanger.
Fax j33 4 67 54 23 78. e-mail pboulang!infobiogen.fr sponded to the C-terminal region of nucleocapsid (NC), including the second zinc finger, the intermediate spacer peptide sp2 and the N-terminal half of the p6 domain. Deletions in these Gag domains significantly decreased the Vif encapsidation efficiency, and complete deletion of NC abolished Vif encapsidation. In Vif, four discrete Gag-binding sites were identified, within residues T 68 -L 81 (site I) and W
89
-P 100 (site II) in the central domain, and within residues P 162 -R 173 (III) and P 177 -M 189 (IV) at the C terminus. Substitutions in site I and deletion of site IV were detrimental to Vif encapsidation, whereas substitution of basic residues for alanine in sites III and IV had a positive effect. The data suggest a direct intracellular Gag-Vif interaction and the occurrence of a Pr55Gag-mediated membranetargeting pathway for Vif in Sf9 cells.
microscope (Ho$ glund et al., 1994 ; or from a defect in entry and\or uncoating of the input virions (Borman et al., 1995 ; Trono, 1995 ; von Schwedler et al., 1993) . The Vif(k) virions only show their defective phenotype in certain cell types (Courcoul et al., 1995 ; Sova et al., 1995 ; von mechanism and role of Vif incorporation into HIV-1 particles still remain elusive (Camaur & Trono, 1996) .
HIV-1 wild-type (WT) Gag precursor (Pr55Gag) expressed by recombinant baculovirus in insect cells has been found to be assembled and released with a high efficiency into the external medium as membrane-enveloped, retrovirus-like particles (Gheysen et al., 1989 ; Hughes et al., 1993 ; Overton et al., 1989 ; Royer et al., 1991 Royer et al., , 1992 . In order to provide further insights into the biological functions carried out by the Vif protein, we analysed the capability of HIV-1 Vif to be encapsidated by Gag particles budding from the plasma membrane of WT Pr55Gag-expressing insect cells. We found significant amounts of Vif wt co-encapsidated with WT Pr55Gag into extracellular virus-like particles. The interacting domains in recombinant Pr55Gag and Vif proteins were then investigated using a phage-displayed hexapeptide library (Smith & Scott, 1993 ) and a ligate-ligand elution method (Hong & Boulanger, 1995 ; Hong et al., 1997) . The biopanning data suggested that the major interacting sites between the two partner proteins were : in Vif, the basic C-terminal domain and two discrete regions in the central domain, between residues 68 and 100 ; and in Pr55Gag, the region spanning the C-terminal portion of the second zinc finger of the nucleocapsid (NC) domain, the spacer peptide sp2 (%$%LGKIWPSYKGRPGNF%%), previously termed p1 ; Craven & Parent, 1996 ; Henderson et al., 1992) , the sp2-p6 junction and the N-terminal proline-rich motif of the p6 domain. Site-directed mutagenesis of Gag and Vif proteins confirmed that the integrity of these domains in Gag and Vif proteins was required for efficient encapsidation of Vif into Gag particles released by insect cells. Introduction of a double mutation affecting both central Gag-binding sites in the vif gene resulted in a Vif(k) phenotype of HIV-1 virions in a Vifrestrictive human cell line .
Methods
Cells, virus infections and metabolic labelling. Spodoptera frugiperda cells (Sf9 subclone), maintained as monolayers, were usually infected at an m.o.i. of 1-10 p.f.u. per cell. In co-infection experiments cells were simultaneously infected with two recombinant baculoviruses at the same m.o.i. of 5 p.f.u. per cell. Labelling of recombinant proteins with [$&S]methionine and [$&S]cysteine was performed at 100 µCi\ml of $&S (Tran$&S-label, ICN ; 1380 Ci\mmol) at 6 h post-infection (p.i.) for 30 h. For quantification of co-encapsidated Gag and Vif proteins, Gag particles were isolated by ultracentrifugation and analysed by SDS-PAGE as described below, and the amount of radioactivity in their respective polypeptide bands was measured by a PhosphorImager (Molecular Dynamics-435 SI).
Construction of recombinant baculoviruses expressing Gag or Vif. The construction and phenotypes of recombinant baculoviruses expressing the WT Pr55Gag (Gag12myr + ), its unmyristoylated version G2A, and N-myristoylated (denoted + ) mutants used in this study, Gagin438 + , Gagamb462 + , Gagamb438 + , Gagamb426 + and Gagamb374 + , have been described in detail in previous studies Chazal et al., 1994 Chazal et al., , 1995 Royer et al., 1991 Royer et al., , 1992 . Their sequence characteristics are summarized in Table 1 . The internal deletion mutant Gagdl427-438 + was constructed by using the two baculovirus transfer vectors containing the gag gene of Gagin426 + and of Gagin438 + , respectively. The N-terminal moiety of the gag gene sequence of Gagin426 + was ligated to the C-terminal moiety of the gag sequence of Gagin438 + , both being cut at the unique EcoRI site present in their insertion linker (Chazal et al., 1994) . This removed the C-terminal portion of NC after the second zinc finger, the NC-sp2 junction and the Nterminal portion of the sp2 domain until tryptophan-438 (Table 1) . For Gagdl437-444 + , the gag gene sequence was cut with BglII at nucleotide position 1642 and HaeIII at position 1666 in HIV-1 LAI (Wain-Hobson et al., 1985) , blunted and religated. This removed most of the sp2 domain, from residue isoleucine-437 to arginine-444 (Table 1) . Gagdl41-143 + , was constructed by ligating the 5h end of the gag gene cut at the AluI site at position 40 to the blunted EcoRI site of the Gagin143 + insertion linker (Chazal et al., 1994) . This removed the C-terminal two-thirds of the MA domain, from residue 41 to the MA-CA junction, and a few amino acids from the CA, up to residue 143 (Table 1) .
The recombinant Vif clones carrying substitutions (sub) in motif E('REWH)! (mutated to D('INQN)!), W)*RKRRY*% (mutated to F)*EKRRF*%) and the double mutant D('INQN)!-\\-F)*EKRRF*% were referred to as VifsubA, VifsubB and VifsubC, respectively (Table 1) . They were all derived from the HIV-1 molecular clone pNDK (Spire et al., 1989) , and were generated by site-directed mutagenesis as described in a parallel study . The Vif substitution mutant KR-A8 was the recombinant baculovirus clone equivalent to mutant B7 (Goncalves et al., 1995) , in which eight C-terminal basic residues (K"&(, K"&), K"'!, R"($, K"(', K"(*, K")" and R")%) of the full-length Vif were replaced by alanine (Table 1) . Four C-terminal deletion (ct) mutants of Vif, carrying a stop codon in lieu of glutamate-171 and lacking the C-terminal 22 residues, were also constructed. They were abbreviated Vifct170 for the single ct-mutant, Vifct170-A, Vifct170-B and Vifct170-C, respectively, for the ct clones containing the substitutions A, B or C described above (Table 1) . The WT and mutant vif genes were isolated using the Pfu proof-reading thermostable DNA polymerase (Stratagene) and the following oligonucleotide primers.
Vif\Nco (sense) 5h CCCATGCCATGGAAAACAGATGGCAGGT-GATGATTGTG 3h (nt 5032-5061) Vif\Kpn (antisense) 5h GGGGGTACCTCTTAAGCTCCTCTAAA-AGCTCTAATG 3h (nt 5628-5608) After digestion with NcoI and KpnI, the PCR fragment was inserted into the NcoI and KpnI sites of the transfer vector pGmAc115T-N (Carrie ' re et al., 1995) , and recombinant baculoviruses were obtained by in vivo recombination within Sf9 cells between the transfer vector carrying the vif gene and Bsu36I-digested DNA from the AcNPV-derived BacPAK6 virus (Clontech). The vif genes were therefore expressed, like our gag gene constructs, under the control of the polyhedrin promoter. The genomes of all mutants were verified by DNA sequence analysis.
Gag particle analyses. Gag particles were analysed by ultracentrifugation in sucrose-D # O gradients (Liu et al., 1995) , with some modifications. Culture fluids of Gag and Vif co-expressing Sf9 cells were digested with subtilisin (100 µg\ml) and papain (50 µg\ml, in the presence of 1 mM 2-mercaptoethanol) at room temperature for 16 h. The aim of this was to hydrolyse soluble or external, membrane-bound Vif protein (Goncalves et al., 1995 ; Simon et al., 1997) which would not be truly Gag-encapsidated, and could contaminate the Gag particle fractions. Digestion was arrested by addition of PMSF and H # O # , up to 0n5 mM and 2 mM, respectively. Linear gradients (10 ml total volume, 30-50 %, w\v) were centrifuged for 18 h at 28 000 r.p.m. in a Beckman SW41 rotor. The 50 % sucrose solution was made in D # O buffered to pH 7n2 with NaOH, and the 30 % sucrose solution was made in 10 mM Tris-HCl, pH 7n2, 150 mM NaCl, 5n7 mM Na # EDTA. Aliquots of 0n4 ml were (Goncalves et al., 1995) ], the mutated basic amino acids are underlined, and the alanine residues substituting for them positioned underneath.
Clone designation WT amino acid sequence Mutant sequence
collected from the bottom. Proteins were analysed by SDS-PAGE in 12n5 % acrylamide gels using a discontinuous buffer system (Laemmli, 1970) .
Immunoblot analysis and antibodies. Immunoblotting of proteins analysed by SDS-PAGE was carried out as described in previous studies Chazal et al., 1994 Chazal et al., , 1995 . HIV-1 MA protein antiserum was laboratory-made. It was raised in rabbit by injection of GST-fused, bacterially expressed (pGEX-KG ; Guan & Dixon, 1991) HIV-1 MAp17, purified by affinity chromatography, preparative SDS-gel and electro-elution (Elutrap BT 1000, Schleicher & Schuell). Rabbit anti-Vif serum was kindly provided by D. Gabuzda (Dana Farber Cancer Institute, Boston, USA). The working dilution in blotting experiments was 1 : 5000 for both antisera. Monoclonal antibody (MAb) HH3, directed against a C-terminal epitope of the NC domain (Tanchou et al., 1994) , was kindly provided by R. Benarous (Faculte! de Me! decine Cochin-Port Royal, Paris, France). Phosphatase-labelled and horseradish peroxidase-labelled anti-rabbit IgG conjugates, purchased from Sigma and Boehringer Mannheim, respectively, were used at a dilution of 1 : 1000 in Trisbuffered saline containing 0n05 % Tween 20 (TBS-T). For luminograms, chemiluminescent peroxidase substrate Supersignal (Pierce) was used. For immunological quantification of Gag and Vif proteins, blots were reacted with "#&I-labelled anti-rabbit whole IgG antibody (Amersham ; 6n9 µCi\µg ; 2 µCi per blot of 200 cm#) and exposed to radiographic films (Hyperfilm-βmax, Amersham). Autoradiograms were scanned at 610 nm, using an automatic densitometer (REP-EDC, Helena Laboratories). Protein bands were also excised from blots and radioactivity was measured in a scintillation counter (Beckman LS-6500).
Electron microscopy (EM) and immunoelectron microscopy (IEM).
For conventional EM, baculovirus-infected Sf9 cells were harvested at 40 h p.i., pelleted, fixed with 2n5 % glutaraldehyde in 0n1 M phosphate buffer, pH 7n5, post-fixed with osmium tetroxide (2 % in H # O) and treated with tannic acid (0n5 % in H # O). After dehydration, the specimens were embedded in Epon. Sections were stained with 2n6% alkaline lead citrate and 0n5 % uranyl acetate in 50 % ethanol, and poststained with uranyl acetate (0n5 % in H # O). For IEM and antibodyimmunogold labelling , cell specimens were embedded in hydrophilic metacrylic resin (Lowicryl K4M), and sections were reacted with anti-Vif rabbit antibody diluted to 1 : 100 in TBS overnight at 4 mC. Reaction with gold-labelled secondary antibody was carried out at room temperature for 1 h, using anti-rabbit IgG immunoglobulins (diluted at 1 : 10 in TBS) labelled with 5 nm colloidal gold particles (EM-GAM5 ; BioCell Research). Sections were post-stained with 0n5 % uranyl acetate. Specimens were examined under an Hitachi-H7100 electron microscope. Quantitative IEM was performed on immunogold-labelled sections, by scanning EM photographs using an image analyser (Agfa Arcus2-PCF) and counting gold grains in different cell compartments, using the NIH Image program, version 1.60.
Phage biopanning. The filamentous phage-displayed hexapeptide library was kindly provided by G. Smith (Scott & Smith, 1990) . Affinity biopanning of phages binding to immobilized protein was carried out following published protocols (Smith and Scott, 1993) , with minor modifications with respect to specific ligand elution (Hong & Boulanger, 1995 ; Hong et al., 1997) . Mutant GagG2A, the unmyristoylated form of Pr55Gag, which releases Gag as soluble polyprotein (Chazal et al., 1994) , was used in biopanning experiments. Both GagG2A and Vif wt proteins were isolated from cell culture supernatant of baculovirus-infected cells by ammonium sulphate precipitation [60 % saturation in (NH % ) # SO % ]. When GagG2A was immobilized on the solid support, elution of phages was carried out using Vif wt protein as the soluble competing ligand. Alternatively, with immobilized Vif wt , phages were eluted by competition with soluble GagG2A. The hexapeptide phagotopes were identified by DNA sequencing of the recombinant fUSE5 pIII protein, using the dideoxynucleotide chain termination method (Sanger et al., 1987) , oligonucleotide 5h TGAATTTTCTGTATGAGG 3h as the primer, and Sequenase kit version 2.0 (Amersham). Multiple sequence alignment was performed using the W(1.4) version of the Clustal program (Higgins & Sharp, 1988) .
Results

Expression and cellular localization of recombinant Vif wt and Vif mutant proteins in insect cells
The levels of synthesis and stability of Vif wt and of each Vif mutant were analysed by SDS-PAGE and immunoblotting of extracts from cells harvested at different times p.i. None of the Vif clones was apparently toxic for Sf9 cells. All were detectable as early as 18 h p.i. and accumulated as stable recombinant proteins, and no significant proteolytic degradation was observed until 48 h p.i. (Fig. 1 a) .
The cellular localization of recombinant Vif proteins was analysed by EM and IEM, as shown in Fig. 1 (b) . Vif wt protein accumulated mainly in the nucleus of Sf9 cells, and no significant labelling of Vif was found at the plasma membrane. The ratio of the density of immunogold-labelled anti-Vif (Table 2 ) the VifKR-A8 labelling was mainly found within the cytoplasm (C) and not the nucleus (N). Bar, 600 nm.
antibodies (number of gold grains per µm# surface area) between nucleus (N) and cytoplasm (C) observed in cell sections was found to be 7n34p0n80 (meanpSD, Table 2 ). VifsubA mutant protein was also found to predominantly localize in the nuclear compartment, although with a slightly lower efficiency than WT (mean N : C ratio of 4n2). In the case of mutants VifsubB and VifsubC, the N : C ratio of Vif labelling was significantly reduced, with mean N : C ratios of 1n3 and 0n9, respectively. This suggested that the motif which had been mutated in VifsubB, W)*RKRRY*%, acted as a nuclear localization signal in insect cells, a function which has not yet been assigned to any domain of Vif thus far. Likewise, mutant VifKR-A8, which was mutated in the two basic subdomains of the C-terminus (Goncalves et al., 1995) , was poorly transported to the nucleus (Fig. 1 b) , whereas Vifct170, in which only the most C-terminal basic subdomain was deleted, localized equally within the cytoplasm and nucleus (Table 2 ). This suggested that the proximal basic motif KKIK at position 157-160, located between two bend-generating proline residues, also acted as a nuclear addressing signal.
Co-encapsidation of WT Pr55Gag and Vif wt
When Pr55Gag was co-expressed in Sf9 cells with Vif protein provided in trans by a second, co-infecting, recombinant baculovirus, Gag particles were released by budding from the plasma membrane with the same efficiency as from single-infected cells (data not shown). Thus, co-expression of Vif wt protein had no apparent detrimental effect on Gag Data represent the ratio of the number of gold grains per µm# of nucleus or cytoplasm surface area (pSD, at P l 0n05), as shown in Fig. 1 (b) . The number of Vif-associated 5 nm immunogold grains counted ranged from 1000 to 11 000 in at least five different pictures of Sf9 cell sections, with grain density ranging from 70 to 350 grains per µm# of cell surface area. Table 2 ). Similarly, the N : C ratio of Vif decreased 6-fold in coexpression of VifsubA with Pr55Gag (Table 2 ). This strongly suggested that Pr55Gag contributed to the maintenance of the Vif molecules within the cytoplasm, and\or to retargeting Vif to the plasma membrane, as shown by IEM examination of the surface of co-infected cells. Colloidal gold grain-labelled antiVif antibodies were found to be associated with plasma membrane-budding and extracellular Gag particles, suggesting that Vif was efficiently co-packaged with Gag precursor into retrovirus-like particles (Fig. 2) . Vif encapsidation into Gag particles was confirmed by sedimentation analysis of Gag particles released in cell culture supernatants of co-infected cells. Significant amounts of Vif wt protein were found to co-sediment with Pr55Gag in a sucrose-D # O gradient, and to band at the apparent density of the Gag particles (Fig. 3 a) . To eliminate the possibility of contamination of Gag particulate fractions by membranebound extra-particular Vif protein, cell culture supernatants of Sf9 cells were digested, prior to sedimentation analysis, with subtilisin and papain, under conditions which were optimized to abolish all detectable signal of soluble Vif molecules in single-infected cell culture supernatants (not shown).
The methionine and cysteine contents of WT Pr55Gag and Vif wt proteins were in the ratio of 27 residues in Gag to 8 in Vif (Spire et al., 1989) . After radiolabelling of Sf9 cells coexpressing WT Pr55Gag and Vif wt in steady state, Gag particles isolated in a sucrose density gradient were analysed by SDS-PAGE and autoradiography. The Vif signal represented 1n02p0n18 % (n l 5) of the Pr55Gag label, which, after correction for the sulphur-containing amino acid content ratio, corresponded to 3n45p0n60 copies of Vif per 100 Fig. 2 . EM analysis of Gag-Vif co-encapsidation. (a, b) , Immunoelectron microscopy of Sf9 cells co-expressing WT Pr55Gag and mutant VifsubB, which was found to be encapsidated at WT levels (Table 4) Pr55Gag molecules, or 70p12 copies of Vif wt per virus-like particle if one considers 2000 units of Gag per particle (Table  3) .
Biopanning of Gag and Vif with a phage-displayed hexapeptide library
The interacting domains between recombinant Pr55Gag polyprotein and Vif wt protein were investigated using a phage-biopanning method (Scott & Smith, 1990 ; Smith & Scott, 1993) , in which Gag and Vif were alternately used as the immobilized ligate and the soluble competing ligand (Hong & Boulanger, 1995 ; Hong et al., 1997) . Phages eluted from immobilized Gag by competition with soluble Vif wt protein were expected to carry phagotopes mimicking the Gagbinding sites in Vif wt , whilst phages eluted from immobilized Vif wt protein by competition with soluble Gag would carry mimotopes of the Vif-binding sites in Gag.
A set of 50 phages thus isolated from Vif wt by specific GagG2A elution were sequenced. The results of sequence comparison and alignment with Pr55Gag are shown in Fig.  4(a) The isolated phagotopes spanned a continuous region of Gag between histidine-421 and threonine-470. A group of nine phagotopes contained the bulky tryptophan residue and were consensus to motifs present in the sp2 spacer peptide at the NC-p6 junction. In particular, the LLIWSP hexapeptide ‡ Number of Vif copies per particle, assuming an average number of 2000 molecules of Pr55Gag per particle (Layne et al., 1992) . The ratio of Vif wt to WT Pr55Gag molecules was calculated from the radioactivity found in Vif and Gag proteins recovered from virus-like particles isolated from cell cultures labelled with [$&S]cysteinejmethionine. For all the Gag mutants, the Vif copy number was then derived from the values of encapsidation efficiency in the previous column. § For Gagdl41-143 + , which has most of the MA domain deleted, the immunological assay, as shown in the column ' Vif : Gag ratio', could not apply, and data were obtained from the $&S-content of the proteins, by taking into account the deletion of one methionine and two cysteine residues from Gag. , Not detected ; , not applicable.
was homologous to motif IWPS in sp2. Other phagotope motifs were also recognized in the Gag linear sequence, like FAGRSW, a mimotope of the NC-sp2 junction F\LKKIW, or PNGRFD, which mimicked the sp2\p6 junction PGNF\LQ. Further downstream in Pr55Gag, the conserved, hydroxylicand proline-rich sequence SRPEPTAPPEES of the p6 domain was represented several times in phagotopes as LVRTVP, TKPGVT, YVEPSP, RTLPPQ, IPPYF and TAPSKV. The p6 hydroxylic-rich motif SFRSGVE(T) $ was also found as the homologous phagotopes TVMSGG, ASFRDY, FRTVND, ASQATS and SAVNLT (Fig. 4 a) .
In parallel experiments, Gag-bound phages were eluted by displacement by soluble Vif. Fifty individual clones were isolated and sequenced, and most of the phagotopes thus yielded could be aligned with the Vif sequence. They distributed into four discrete regions in Vif, two of them situated in the central portion of the molecule, two others at its C terminus (Fig. 4 b, c) . A first subdomain, or site I, was identified between threonine-68 and valine-85, and a second site (site II) between glycine-84 and leucine-102. Phagotopes which contained the di-or tri-peptides TY, GLH, HI and WHI had their homologues in the Vif site I as the two distinct motifs TYWGLH and WHLGQ. In site II, the stretch of aromatic residues IEWRKRRYS was partially represented in several phagotopes as ITWR, LWVKRI, WRLGS and IKRY. Likewise, the phagotopes ASQPVY, SEEPAL, AVRSQP, ITSREP and VSTLPL, in which a hydroxylic residue (serine and\or threonine) and a glutamine (and\or glutamic or aspartic acid) neighboured a proline, fitted well with the Vif sequence STQVDPGL within residues 95-102.
The proline-and arginine\lysine-rich C-terminal end of the Vif protein contained two stretches of basic residues, assigned to positions 157-168 and 173-184, respectively (Goncalves et al., 1995) . One-third of all the Vif-phagotopes isolated were characterized by a high frequency in proline, serine\threonine and basic residues, all features shared by the Vif C terminus, and the sequences displayed could be aligned with the Vif Cterminal sequence as two subsets of motifs, each corresponding to one of the two basic subdomains (Fig. 4 c) . The subdomains spanning residues proline-162 to arginine-173 and residues proline-177 to methionine-189, were referred to as sites III and IV, respectively.
The identification of these four sites in the Vif protein, which represented potential Gag-interacting domains, was the rationale for constructing our recombinant Vif mutants : VifsubA and VifsubB were mutated in sites I and II, respectively, and VifsubC was the double mutant in both sites I and II. Mutation in Vifct170 deleted essentially site IV, whereas substitution mutant VifKR-A8 was altered in basic charges of both sites III and IV. On the other hand, the complex carboxy- (Spire et al., 1989) , respectively. (d) Hexapeptide motifs in Gagbound phages, isolated by displacement with anti-NC MAb HH3, are aligned with the Vif C-terminal domain sequence. (2) The phagotope EVYRSH was found in two independent clones. Identical or conserved residues at analogous positions are in bold type. Hyphens were introduced to maximize the alignment.
truncationjsubstitution mutant Vifct170-C kept only one potential Gag binding site intact, i.e. site III (refer to Table 1 and Fig. 4 c) .
Encapsidation of recombinant Vif wt protein in WT and mutant Gag particles
In order to confirm the identification and localization of the Gag-Vif interacting domains defined by our phage biopanning, the interactions of Vif and Gag mutants were analysed by a coencapsidation assay in vivo (Fig. 3) . The panel of Nmyristoylated ( + ) Gag precursor mutants used contained those which have been found to release WT levels of membraneenveloped Gag particles into the extracellular medium Chazal et al., 1995) . Four mutants carried termination codons upstream to the normal Gag C terminus : Gagamb462 + (lacking the p6 C-terminal moiety), Gagamb438 + (sp2-and p6-minus), Gagamb426 + (lacking p6, sp2 and the Cterminal portion of NC, downstream of the second zinc finger), and Gagamb374 + (lacking the entire p6, sp2 and NC domains). Three others were internal deletion (dl) mutants : Gagdl 437-444 + carried a small deletion removing most of the sp2 domain ; the Gagdl427-438 + deletion overlapped the Cterminal portion of the NC (immediately downstream to the second zinc finger) and the NC-sp2 junction ; and the Gagdl41-143 + deletion removed the MA domain downstream to residue 41 and the MA-CA junction (Table 1 ). The insertion mutant Gagin438 + contained the four amino acid motif LEFQ inserted into the sp2 domain, between tryptophan-438 and proline-439 (Chazal et al., 1994) .
Sf9 cells were co-infected with each Gag and Vif recombinant at equal m.o.i., and Gag particles released into the cell culture medium were analysed by ultracentrifugation, SDS-PAGE and immunoblotting with anti-Gag and anti-Vif antibodies. The packaging efficiency of Vif wt by Gag mutants was thus compared with that of Vif wt by WT Pr55Gag (Fig. 3 a, b, and Table 3 ). This efficiency decreased significantly for Gagamb462 + (2n5-fold), and in similar proportions (2-to 3-fold) for Gagamb438 + , Gagdl427-438 + , Gagdl437-444 + and Gagin438 + . The most drastic reduction was observed for Gagamb426 + (10-fold), and for Gagamb374 + , in which no Vif protein signal was detectable. However, Vif wt was encapsidated at WT levels by Gagdl41-143 + (Table 3) . The results obtained with Gagamb374 + , Gagamb426 + and Gagdl 427-438 + implied that the NC domain was essential for Vif encapsidation, as well as the NC-sp2 junction. The results shown by mutants Gagamb438 + and Gagamb462 + suggested that the N-terminal moiety of the p6 domain also had a significant role in Vif encapsidation. The Vif wt encapsidation pattern with sp2-mutants Gagin438 + and Gagdl437-444 + (Fig. 3 b) suggested that alterations of the sp2 domain of Pr55Gag were less critical for the Vif encapsidation process, and that a certain degree of laxity and flexibility in Gag-Vif interactions could occur around the sp2 domain, which would act as a hinge between upstream and downstream binding sites with higher Vif affinity.
Encapsidation of Vif mutants by recombinant WT Pr55Gag
The next experiments were designed to determine the efficiency of Gag particle encapsidation of Vif mutants by WT GagPr55. As shown in Fig. 3 (c, d) and Table 4 , the amount of Vif protein incorporated into Gag particles was reduced by a factor of 2 to 2n5 for the single substitution mutant VifsubA and the double substitution mutant VifsubC. It was 25-to 40-fold lower than Vif wt for the C-truncated mutant Vifct170, and the double mutants Vifct170-A, Vifct170-B and Vifct170-C. This suggested that the Gag-binding site IV, and to a lesser extent site I, had a predominant role in Vif encapsidation, and that no compensatory effect was provided by intact sites II and III. However, VifKR-A8 was found to be encapsidated at levels significantly higher than WT (over 3-fold ; Table 4 ). These results were confirmed by IEM using anti-Vif antibody (Fig. 2 c,  d ). WT Gag particles budding from Sf9 cells co-expressing VifKR-A8 in trans showed stronger immunogold labelling (almost 4-fold) than Gag particles budding from Sf9 cells coexpressing Vif wt : 6n03p1n39 gold grains per extracellular Gag particle (meanpSD ; n l 31) were found for VifKR-A8, versus 1n66p0n42 (n l 59) for Vif wt . On the other hand, a very low level of immunogold labelling was observed for Vifct170, with only 0n57p0n36 (n l 56) grains per Gag particle. The WT level of encapsidation of VifsubB (Table 4) did not exclude site II as one of the Gag-interacting regions in Vif. Unlike substitutions that we generated in VifsubA, which were non-conservative at four positions out of five within residues 76-80, the substitutions created in VifsubB, W)*RKRRY*% to FEKRRF, were conservative in terms of aromatic residues at both critical positions 89 (W F), and 94 (Y F). The only non-conservative change was the R E mutation at position 90. Thus, intact residues in site II and the other Gag-binding sites could still establish enough intermolecular bonds with Gag to bring about normal encapsidation.
Orientation of Vif and Gag molecules within the Gag-Vif complex
Plasma membrane targeting of HIV-1 Pr55Gag, and extracellular budding of membrane-enveloped virions or viruslike particles requires the myristoylation of Pr55Gag at its N terminus (Gheysen et al., 1989 ; Royer et al., 1991 Royer et al., , 1992 Wills & Craven, 1991) . Pr55Gag is thus oriented during the budding process, with its N-terminal end anchored at the plasma membrane. It was therefore of interest to determine the orientation of the Vif protein when complexed with Pr55Gag. To this aim, we used MAb HH3, whose epitope is localized within residues 429-444 (Carrie' re et al., 1995 ; Tanchou et al., 1994) , overlapping the NC-sp2 junction. A library of phages isolated by three cycles of affinity selection on and acid elution from immobilized GagG2A were once again adsorbed onto GagG2A, and phages were eluted by displacement by HH3 (Hong & Boulanger, 1995) . We reasoned that certain HH3-competed phagotopes which had an affinity for the HH3 epitope in Gag would be mimotopes of peptide motifs present in Gag-binding site(s) of Vif (Hong & Boulanger, 1995) and would resemble some of the Vif-displaced phagotopes presented in Fig. 4 (b, c) . Ten phagotopes out of 20 phages isolated and sequenced could thus be put in three groups consensus to discrete regions of the Vif sequence belonging to sites III and IV : the proline-rich motif within residues 158-175, the TK motif at position 180 and the RGSH motif at position 184 (Fig.  4 d) . This suggested that the C-terminal extremity of Vif was oriented towards the NC domain, implying that Vif and Gag were in reverse orientation in the complex.
Discussion
The mechanisms of the regulatory functions of the Vif protein in the HIV-1 life-cycle, and the biochemical bases of Vif incorporation into the virion core, remain poorly understood at the molecular level. In the present study, we analysed Vif and Gag interaction and co-encapsidation in baculovirusinfected insect cells, a cellular context in which only Vif wt or Vif mutants were expressed and provided in trans to the Gag particle assembly and budding machinery. We found that Vif was encapsidated into Gag particles in Sf9 cells co-infected by two recombinant baculoviruses, one expressing Vif wt , the other one expressing the full-length Gag precursor Pr55Gag (Figs 2 and 3) . The number of Vif wt copies in extracellular virus-like particles was found to be 70p12 per 2000 copies of Pr55Gag, a value consistent with the previous estimation of one molecule of Vif for every 20 to 30 molecules of p24 gag in HIV-1 virions (Liu et al., 1995) . IEM analysis showed that a significant proportion of Vif wt molecules accumulated within the nucleus (Table 2) . Vif wt was found to be localized in significant amounts at the plasma membrane and in the cytosol only in the presence of Gag co-expressed in trans in the same cells ( Fig. 2 and Table 2 ). This suggested that Vif was not passively encapsidated into Gag particles, or via plasma membrane (or membrane protein) interaction, but was actively transported to the budding sites after binding to Gag precursor. Co-immunoprecipitation experiments, performed with HIVinfected H9 cell lysates, confirmed that specific Gag-Vif interactions also occurred in human cells .
To identify the interacting domains between Gag precursor and Vif, we biopanned a filamentous phage-displayed hexapeptide library on immobilized Gag and Vif, with elution of Pr55Gag-bound phages by displacement with an excess of Vifligand as soluble competitor, and vice versa (Hong & Boulanger, 1995 ; Hong et al., 1997) . The mimotopes thus isolated suggested that four discrete regions in Vif were involved in Gag recognition. Two sites (I and II) were identified in the central domain, between residues T')-L)" and W)*-P"!!, and two other sites at the C terminus, between residues P"'#-R"($ (site III) and P"((-M")* (site IV). The two latter sites corresponded to the two discrete basic domains previously identified (Goncalves et al., 1995) . They all coincided with regions of the Vif sequence which have a high probability of hydrophilicity and accessibility (Wieland et al., 1991 (Wieland et al., , 1994 . In the corresponding partner protein Pr55Gag, the phagotopes spanned a domain 50 residues in length, from H%#"-T%(!. This corresponded to the C-terminal portion of the NC, including the second zinc finger, the sp2 domain, the sp2-p6 junction and the N-terminal half of the p6 domain, containing the conserved SFRSGVETTT and PEPTAPP motifs (Fig. 4 a) .
The authenticity of these Gag-Vif interacting domains was then studied by in vivo co-encapsidation assays, using a series of mutants of recombinant Gag precursors which were able to assemble Gag and release budding virus-like particles at WT levels from baculovirus-infected cells (Tables 1 and 3 ). The Gag mutants were analysed with respect to the efficiency of encapsidation of Vif wt . Likewise, substitution and deletion mutants of Vif were generated in the Gag-binding sites, and the mutants were assayed for co-encapsidation with WT Pr55Gag (Tables 1 and 4 ). In the Gag precursor, the mapping of the major determinants for Gag-Vif co-encapsidation to the NC and the adjacent sp2 and p6 domains was consistent with the results of Gag-Vif interaction in vitro, using GST-fused amber mutants of Gag precursor .
The Vif mutants, however, showed a more complex pattern of in vivo co-encapsidation (Table 4) and in vitro interaction with the Gag precursor . In Sf9 cells, there was an apparent hierarchy between the four potential Gag interacting sites, with a predominant role for Vif-Gag coencapsidation of C-terminal site IV and central site I. Site I substitution (VifsubA) and site IV deletion (Vifct170), which had a strong negative effect on Vif encapsidation, were not compensated for by intact sites II and III. On the other hand, basic residue-to-alanine substitutions at the C terminus of VifKR-A8 mutant resulted in a higher encapsidation efficiency (Table 4) . In vitro , however, the nascent Vif mutant proteins obtained by cell-free translation, VifsubA, VifsubB and VifsubC, but not Vif-B7 (the equivalent of our VifKR-A8 clone), were capable of binding to GST-Pr55Gag at WT levels . Compared to the 2n5-fold reduction of VifsubA and VifsubC encapsidation and the 3-fold increase in VifKR-A8 encapsidation, this would imply that Vif protein conformation could influence Vif-Gag interaction and co-encapsidation, as well as other factor(s) present at the assembly and budding cell compartment, as previously suggested (Camaur & Trono, 1996) . Our Vif mutations subA, subB and subC were re-introduced into the proviral DNA pNDK, and the resulting molecular clones (pNDK\MutA, pNDK\MutB and pNDK\MutC, respectively) were phenotyped for Vif in a human restrictive cell line . Two other proviral clones, Vif-B4 and Vif-B7 (Goncalves et al., 1995) , which carry multiple basic residue-to-alanine substitutions in the C-terminal domain as in our VifKR-A8 recombinant, were also tested in parallel. Vif-B4, Vif-B7 and pNDK\MutC showed a Vif-defective phenotype, whereas pNDK\MutA had an intermediate phenotype, with a significant delay in replication . This result, and the difference in the encapsidation efficiency between recombinants VifsubA and VifsubC (low) and VifKR-A8 (high) implied that the Vif(k) phenotype of infectious HIV-1 virions did not directly correlate with the capability of Pr55Gag and Vif to be co-encapsidated in vivo. This confirmed that multiple discrete domains in Vif (Ochsenbauer et al., 1996) and factor(s) other than Pr55Gag and the Gag-mediated plasma membrane targeting pathway could account for the biological functions of Vif in HIV-1-infected cells. These factors could be of cellular origin, like membrane-associated protein(s) postulated to mediate the membrane binding of Vif via its C-terminal basic domain (Goncalves et al., 1995) , or of viral origin, like the protease domain of the GagPol polyprotein (Kotler et al., 1997) . A clue to the mechanism of HIV-1 Vif encapsidation would be to study the level of incorporation of recombinant Vif wt protein and its mutants into intracellular Gag particles. This is now being investigated in our laboratory, using unmyristoylated Gag precursor assembled in the cytoplasm or nucleoplasm of insect cells (Royer et al., 1991) .
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